Dr. Buffington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4360 Ferguson Dr Ste 100
Cincinnati, OH 45245Phone+1 513-841-7750Fax+1 513-841-7751
Summary
- Dr. Philip Buffington is an urologist in Cincinnati, OH and is affiliated with multiple hospitals in the area, including Bethesda North Hospital, Good Samaritan Hospital, Mercy Health - Anderson Hospital, Mercy Medical Center, The Jewish Hospital - Mercy Health, and Chillicothe Veterans Affairs Medical Center. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 33 years. He specializes in female urology/pelvic medicine & reconstructive surgery and is experienced in urogynecology and pelvic reconstructive surgery and female pelvic medicine and reconstruction.
Education & Training
- University of Cincinnati Medical Center/College of MedicineResidency, Urology, 1985 - 1991
- Jewish Hospital of CincinnatiInternship, Internal Medicine, 1984 - 1985
- University of Cincinnati College of MedicineClass of 1984
Certifications & Licensure
- OH State Medical License 1985 - 2025
- American Board of Urology Urology
- American Board of Urology Female Pelvic Medicine and Reconstructive Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification meridianEMR, meridianEMR, Inc., 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 18 citationsSuture material in bladder surgery: a comparison of polydioxanone, polyglactin, and chromic catgut.David w. Stewart, Philip J. Buffington, Jeffrey Wacksman
The Journal of Urology. 1990-06-01
Press Mentions
- Bidets Are Becoming More Popular Than Ever — and Medical Professionals ApproveMarch 24th, 2020
- What Your Urine Color Is Trying to Tell YouAugust 24th, 2017
- Obinutuzumab/Venetoclax Combo Highly Effective in CLLDecember 18th, 2015
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: